AMG-333
98%
- Product Code: 63120
CAS:
1416799-28-4
| Molecular Weight: | 453.32 g./mol | Molecular Formula: | C₂₀H₁₂F₅N₃O₄ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD31813692 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
AMG-333 is primarily explored for its potential therapeutic applications, particularly in the field of pain management. It functions as a TRPM8 antagonist, targeting the transient receptor potential melastatin 8 channel, which is involved in the sensation of cold and pain. By inhibiting this channel, AMG-333 has shown promise in alleviating neuropathic and inflammatory pain conditions. Research suggests it could be beneficial in treating conditions like cold allodynia, where patients experience pain from normally non-painful cold stimuli. Additionally, its role in modulating pain pathways makes it a candidate for developing novel analgesics, especially for patients who do not respond well to traditional pain medications. Studies are ongoing to further evaluate its efficacy and safety in clinical settings.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | $331.34 |
+
-
|
| 0.025 | 10-20 days | $715.12 |
+
-
|
| 0.050 | 10-20 days | $1,427.52 |
+
-
|
AMG-333
AMG-333 is primarily explored for its potential therapeutic applications, particularly in the field of pain management. It functions as a TRPM8 antagonist, targeting the transient receptor potential melastatin 8 channel, which is involved in the sensation of cold and pain. By inhibiting this channel, AMG-333 has shown promise in alleviating neuropathic and inflammatory pain conditions. Research suggests it could be beneficial in treating conditions like cold allodynia, where patients experience pain from normally non-painful cold stimuli. Additionally, its role in modulating pain pathways makes it a candidate for developing novel analgesics, especially for patients who do not respond well to traditional pain medications. Studies are ongoing to further evaluate its efficacy and safety in clinical settings.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :